Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received US FDA 510(k) clearance.
مزید پڑھ یہاں.
پیغام [AIMed میں اسکوپیو] ڈیجیٹائزیشن کے ساتھ خوردبین کو تبدیل کرنا پہلے شائع ہمارا کراؤڈ بلاگ.